PENNSYLVANIA
|
No.
23-0993790
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
(I.R.S.
Employer
Identification
No.)
|
One
Quaker Park
901
E. Hector Street
Conshohocken,
Pennsylvania 19428
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(610)
832-4000
|
(Registrant’s
telephone number, including area
code)
|
(Former
name or former address, if changed since last
report)
|
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Exhibit
No.
|
|
99.1
|
Press
Release of Quaker Chemical Corporation dated April 27,
2010.
|
99.2 | Supplemental Information related to first quarter ended March 31, 2010. |
QUAKER
CHEMICAL CORPORATION
Registrant
|
|||
Date: April
27, 2010
|
By:
|
/s/
Mark A. Featherstone
|
|
Mark
A. Featherstone
Vice
President and
Chief
Financial Officer
|
NEWS
|
||
For
Release:
Immediate
|
Contact:
Mark
A. Featherstone
Vice President
and
Chief
Financial Officer
610-832-4160
|
|
|
·
|
Q1
2010 diluted EPS of $0.84 vs. breakeven Q1
2009
|
|
·
|
Product
volumes up 35% from Q1 2009
|
|
·
|
Net
debt-to-total capital ratio improved to 24% vs. 31% at March 31,
2009
|
(Unaudited)
|
||||||||
Three
Months Ended March 31,
|
||||||||
2010
|
2009
|
|||||||
Net
sales
|
$ | 128,320 | $ | 98,507 | ||||
Cost
of goods sold
|
80,980 | 69,793 | ||||||
Gross
margin
|
47,340 | 28,714 | ||||||
%
|
36.9 | % | 29.1 | % | ||||
Selling,
general and administrative expenses
|
33,669 | 26,697 | ||||||
Restructuring
and related charges
|
- | 2,289 | ||||||
Operating
income (loss)
|
13,671 | (272 | ) | |||||
%
|
10.7 | % | -0.3 | % | ||||
Other
income, net
|
763 | 1,454 | ||||||
Interest
expense, net
|
(1,127 | ) | (1,089 | ) | ||||
Income
before taxes and equity in net loss of associated
companies
|
13,307 | 93 | ||||||
Taxes
(tax benefit) on income before equity in net loss of associated
companies
|
3,181 | (251 | ) | |||||
Income
before equity in net loss of associated companies
|
10,126 | 344 | ||||||
Equity
in net loss of associated companies
|
(89 | ) | (142 | ) | ||||
Net
income
|
10,037 | 202 | ||||||
Less:
Net income attributable to noncontrolling interest
|
618 | 200 | ||||||
Net
income attributable to Quaker Chemical Corporation
|
$ | 9,419 | $ | 2 | ||||
%
|
7.3 | % | 0.0 | % | ||||
Per share
data:
|
||||||||
Net
income attributable to Quaker Chemical Corporation Common Shareholders -
basic
|
$ | 0.85 | $ | - | ||||
Net
income attributable to Quaker Chemical Corporation Common Shareholders -
diluted
|
$ | 0.84 | $ | - |
(Unaudited)
|
||||||||
March
31,
|
December
31,
|
|||||||
2010
|
2009
|
|||||||
ASSETS
|
||||||||
Current
assets
|
||||||||
Cash
and cash equivalents
|
$ | 24,820 | $ | 25,051 | ||||
Construction
fund (restricted cash)
|
407 | 2,358 | ||||||
Accounts
receivable, net
|
110,587 | 108,793 | ||||||
Inventories,
net
|
54,458 | 50,040 | ||||||
Prepaid
expenses and other current assets
|
12,929 | 12,656 | ||||||
Total
current assets
|
203,201 | 198,898 | ||||||
Property,
plant and equipment, net
|
65,561 | 67,426 | ||||||
Goodwill
|
45,509 | 46,515 | ||||||
Other
intangible assets, net
|
5,272 | 5,579 | ||||||
Investments
in associated companies
|
8,836 | 8,824 | ||||||
Deferred
income taxes
|
31,510 | 31,692 | ||||||
Other
assets
|
46,941 | 39,537 | ||||||
Total
assets
|
$ | 406,830 | $ | 398,471 | ||||
LIABILITIES
AND EQUITY
|
||||||||
Current
liabilities
|
||||||||
Short-term
borrowings and current portion of long-term debt
|
$ | 2,485 | $ | 2,431 | ||||
Accounts
and other payables
|
56,949 | 60,939 | ||||||
Accrued
compensation
|
10,443 | 16,656 | ||||||
Accrued
pension and postretirement benefits
|
4,702 | 4,717 | ||||||
Other
current liabilities
|
16,700 | 15,224 | ||||||
Total
current liabilities
|
91,279 | 99,967 | ||||||
Long-term
debt
|
71,099 | 63,685 | ||||||
Deferred
income taxes
|
8,613 | 8,605 | ||||||
Accrued
pension and postretirement benefits
|
26,865 | 27,602 | ||||||
Other
non-current liabilities
|
45,859 | 42,317 | ||||||
Total
liabilities
|
243,715 | 242,176 | ||||||
Equity
|
||||||||
Common
stock, $1 par value; authorized 30,000,000 shares; issued
11,151,787
|
11,152 | 11,086 | ||||||
Capital
in excess of par value
|
30,277 | 27,527 | ||||||
Retained
earnings
|
129,994 | 123,140 | ||||||
Accumulated
other comprehensive loss
|
(14,058 | ) | (10,439 | ) | ||||
Total
Quaker shareholders' equity
|
157,365 | 151,314 | ||||||
Noncontrolling
interest
|
5,750 | 4,981 | ||||||
Total
equity
|
163,115 | 156,295 | ||||||
Total
liabilities and equity
|
$ | 406,830 | $ | 398,471 |
(Unaudited)
|
||||||||
2010
|
2009
|
|||||||
Cash
flows from operating activities
|
||||||||
Net
income
|
$ | 10,037 | $ | 202 | ||||
Adjustments
to reconcile net income to net cash (used in) provided by operating
activities:
|
||||||||
Depreciation
|
2,593 | 2,458 | ||||||
Amortization
|
254 | 257 | ||||||
Equity
in net loss of associated companies, net of dividends
|
89 | 142 | ||||||
Deferred
compensation and other, net
|
289 | (2,852 | ) | |||||
Stock-based
compensation
|
727 | 352 | ||||||
Restructuring
and related charges
|
- | 2,289 | ||||||
Gain
on disposal of property, plant and equipment
|
(32 | ) | (1,193 | ) | ||||
Insurance
settlement realized
|
(345 | ) | (144 | ) | ||||
Pension
and other postretirement benefits
|
(2,265 | ) | (1,907 | ) | ||||
Increase
(decrease) in cash from changes in current assets and current liabilities,
net of acquisitions:
|
||||||||
Accounts
receivable
|
(3,606 | ) | 7,196 | |||||
Inventories
|
(5,332 | ) | 10,060 | |||||
Prepaid
expenses and other current assets
|
(1,360 | ) | 34 | |||||
Accounts
payable and accrued liabilities
|
(5,818 | ) | (6,045 | ) | ||||
Change
in restructuring liabilities
|
- | (2,652 | ) | |||||
Net
cash (used in) provided by operating activities
|
(4,769 | ) | 8,197 | |||||
Cash
flows from investing activities
|
||||||||
Capital
expenditures
|
(2,042 | ) | (2,375 | ) | ||||
Payments
related to acquisitions
|
- | (1,000 | ) | |||||
Proceeds
from disposition of assets
|
41 | 1,605 | ||||||
Insurance
settlement received and interest earned
|
5,038 | 5,056 | ||||||
Change
in restricted cash, net
|
(2,742 | ) | (4,086 | ) | ||||
Net
cash provided by (used in) investing activities
|
295 | (800 | ) | |||||
Cash
flows from financing activities
|
||||||||
Net
decrease in short-term borrowings
|
- | (1,619 | ) | |||||
Proceeds
from long-term debt
|
7,583 | 1,584 | ||||||
Repayments
of long-term debt
|
(122 | ) | (7,728 | ) | ||||
Dividends
paid
|
(2,550 | ) | (2,492 | ) | ||||
Stock
options exercised, other
|
135 | 69 | ||||||
Excess
tax benefit related to stock option exercises
|
321 | - | ||||||
Net
cash provided by (used in) financing activities
|
5,367 | (10,186 | ) | |||||
Effect
of exchange rate changes on cash
|
(1,124 | ) | (126 | ) | ||||
Net
decrease in cash and cash equivalents
|
(231 | ) | (2,915 | ) | ||||
Cash
and cash equivalents at the beginning of the period
|
25,051 | 20,892 | ||||||
Cash
and cash equivalents at the end of the period
|
$ | 24,820 | $ | 17,977 |